Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Plaque Psoriasis
Interventions
DRUG

IDP-118 Lotion

Lotion

DRUG

IDP-118 Monad HP Lotion

Active Comparator

DRUG

IDP-118 Monad Taz Lotion

Active Comparator

DRUG

IDP-118 Vehicle Lotion

Vehicle

Trial Locations (18)

10075

Valeant Site 03, New York

14623

Valeant Site 17, Rochester

20850

Valeant Site 04, Rockville

23507

Valeant Site 12, Norfolk

24501

Valeant Site 18, Lynchburg

27262

Valeant Site 02, High Point

30263

Valeant Site 09, Newnan

30909

Valeant Site 10, Augusta

40217

Valeant Site 08, Louisville

48038

Valeant Site 14, Clinton Township

55432

Valeant Site 07, Fridley

77845

Valeant Site 06, College Station

78759

Valeant Site 05, Austin

84117

Valeant Site 16, Salt Lake City

91436

Valeant Site 13, Encino

92123

Valeant Site 11, San Diego

95403

Valeant Site 15, Santa Rosa

08520

Valeant Site 01, East Windsor

Sponsors
All Listed Sponsors
collaborator

Dow Pharmaceutical Sciences

INDUSTRY

lead

Bausch Health Americas, Inc.

INDUSTRY